Markets:

Overview

News

Currencies

International

Treasuries

MacroGenics, Inc. - Common Stock (NQ:MGNX)

3.420 -0.180 (-5.00%)

Streaming Delayed Price Updated: 3:01 PM EDT, Apr 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about MacroGenics, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 05, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 5, 2022 ↗

May 05, 2022

Upgrades

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2022 ↗

May 04, 2022

Upgrades

Via Benzinga

Recap: Macrogenics Q4 Earnings ↗

February 24, 2022

Macrogenics (NASDAQ:MGNX) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

February 14, 2022

During Monday's session, 291 companies made new 52-week lows. Also check out this: Insiders Buying These 4 Penny Stocks Noteable 52-Week Lows And Highs: SAP (...

Via Benzinga

81 Biggest Movers From Yesterday ↗

May 05, 2022

Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares climbed 62.4% to close at $2.16 on Wednesday after gaining around 5% on Tuesday.

Via Benzinga

6 Analysts Have This to Say About Macrogenics ↗

May 04, 2022

Macrogenics (NASDAQ:MGNX) has observed the following analyst ratings within the last quarter:

Via Benzinga

Synaffix, MacroGenics Ink Pact For Next Generation Antibody-Drug Conjugates ↗

February 03, 2022

Synaffix BV has

Via Benzinga

Earnings Scheduled For November 2, 2021 ↗

November 02, 2021

Companies Reporting Before The Bell • Thomson Reuters (NYSE:TRI) is expected to report quarterly earnings at $0.48 per share on revenue of $1.86 billion. •...

Via Benzinga

50 Stocks Moving In Wednesday's Mid-Day Session ↗

May 04, 2022

Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares jumped 51.7% to $2.0180 after gaining around 5% on Tuesday. Sharps Technology, Inc. (NASDAQ: STSS) rose 31.4% to $1.6815 after...

Via Benzinga

Macrogenics: Q1 Earnings Insights ↗

May 03, 2022

Macrogenics (NASDAQ:MGNX) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Macrogenics missed estimated earnings...

Via Benzinga

Macrogenics's Earnings Outlook ↗

May 02, 2022

Macrogenics (NASDAQ:MGNX) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Macrogenics will...

Via Benzinga

What 4 Analyst Ratings Have To Say About Macrogenics ↗

February 28, 2022

Analysts have provided the following ratings for Macrogenics (NASDAQ:MGNX) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2022 ↗

February 28, 2022

Upgrades According to DA Davidson, the prior rating for Envestnet Inc (NYSE:ENV) was changed from Neutral to Buy. In the fourth quarter, Envestnet showed an EPS of $0.50, compared...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

February 25, 2022

Gainers Aerie Pharmaceuticals (NASDAQ:AERI) shares increased by 28.1% to $7.56 during Friday's regular session. Trading volume for Aerie Pharmaceuticals's stock is...

Via Benzinga

93 Biggest Movers From Friday ↗

February 28, 2022

Gainers Inspirato Incorporated (NASDAQ: ISPO) shares surged 50.5% to close at $54.90. Guardforce AI Co., Limited (NASDAQ: GFAI) jumped 45.4% to settle at $0.5979 on Friday. EF...

Via Benzinga

45 Stocks Moving In Friday's Mid-Day Session ↗

February 25, 2022

Gainers KAR Auction Services, Inc. (NYSE: KAR) shares climbed 39.2% to $19.05 after the company agreed to sell its ADESA U.S. physical auction business to Carvana for $2.2...

Via Benzinga

The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company ↗

February 24, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (...

Via Benzinga

The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow ↗

February 20, 2022

Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 4, 2022 ↗

February 04, 2022

Upgrades CBRE upgraded the previous rating for Penn National Gaming Inc (NASDAQ:PENN) from Hold to Buy. For the fourth quarter, Penn National Gaming had an EPS of $0.26,...

Via Benzinga

MacroGenics (MGNX) Q3 2021 Earnings Call Transcript ↗

November 03, 2021

MGNX earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US ↗

November 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus SAB Spikes On Analyst Action SAB Biotherapeutics, Inc. (NASDAQ: SABS) shares...

Via Benzinga

Week In Review: MicroTech Medical Staging $245 Million HK IPO For Diabetes Products ↗

October 10, 2021

MicroTech Medical, a Hangzhou company that offers diabetes monitoring and treatment devices, is conducting a Hong Kong IPO that would raise $254 million at the top of the price range. LianBio has filed...

Via Talk Markets

Topics Initial Public Offering

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2021 ↗

October 19, 2021

Upgrades Maxim Group upgraded the previous rating for Indaptus Therapeutics Inc (NASDAQ:

Via Benzinga

Last Week's Notable Insider Buys Included Evergy, Frontier Communications And More ↗

October 02, 2021

Insider buying can be an encouraging signal for potential investors, especially when markets are uncertain. The week's most notable insider buys were at an REIT, a...

Via Benzinga

3 Stocks Insiders Are Buying ↗

October 01, 2021

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go...

Via Benzinga

Why Are I-Mab Shares Trading Higher On Tuesday? ↗

September 28, 2021

The Center for Drug Evaluation of China National Medical Products Administration has signed off I-Mab's (NASDAQ: IMAB) IND application to initiate a Phase 2...

Via Benzinga

Notable Insider Buys Of The Past Week Include Designer Brands, MacroGenics And More ↗

September 25, 2021

Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. The week's most notable insider buys were at two...

Via Benzinga

56 Biggest Movers From Yesterday ↗

September 17, 2021

Check out these big penny stock gainers and losers Losers Vera Therapeutics, Inc. (NASDAQ: VERA) shares tumbled 26.5% to settle at $22.48. MacroGenics, Inc. (NASDAQ...

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.